Showing results (1881-1890 of 3,475) with videos related to
Sort By:
Pageof 348
Clinical Pharmacokinetics|January 1, 1996
Clinical pharmacokinetics and pharmacodynamics of finasterideJ F SteinerClinical Pharmacokinetics|July 1, 1996
The clinical pharmacokinetics of famciclovirK S Gill, M J WoodClinical Pharmacokinetics|July 1, 1996
Clinical pharmacokinetics of nasal nicotine delivery. A review and comparison to other nicotine systemsN G Schneider, E Lunell, R E Olmstead, et al.Clinical Pharmacokinetics|April 11, 2008
Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilateJoachim StangierClinical Pharmacokinetics|April 11, 2008
Determinants of steady-state torasemide pharmacokinetics: impact of pharmacogenetic factors, gender and angiotensin II receptor blockersDierk Werner, Ulrike Werner, Annett Meybaum, et al.Clinical Pharmacokinetics|April 11, 2008
Effect of coadministered ketoconazole, a strong cytochrome P450 3A4 enzyme inhibitor, on the pharmacokinetics of ciclesonide and its active metabolite desisobutyryl-ciclesonideGabriele M Böhmer, Anton Drollmann, Christoph H Gleiter, et al.Clinical Pharmacokinetics|May 16, 2008
Potential of pharmacokinetic profiling for detecting herbal interactions with drugsVeronika Butterweck, Hartmut DerendorfClinical Pharmacokinetics|May 16, 2008
Pharmacodynamic analysis of recombinant human erythropoietin effect on reticulocyte production rate and age distribution in healthy subjectsJuan José Pérez-Ruixo, Wojciech Krzyzanski, Jeremy HingClinical Pharmacokinetics|May 1, 2025
Scoping Review of Paediatric Population Pharmacokinetic Models of MorphineMichael A Stokes, Noha A Kamel, Marino S Festa, et al.Clinical Pharmacokinetics|March 29, 2025
Pharmacokinetics and Safety of Levofloxacin for Treatment of Rifampicin-Resistant Tuberculosis During Pregnancy and the Postpartum Period: Results from IMPAACT P1026sJennifer A Hughes, Mauricio Pinilla, Kristina M Brooks, et al.Pageof 348